Thomas Andre's most recent trade in Kadant, Inc. was a trade of 768 Restricted Stock Unit done . Disclosure was reported to the exchange on March 10, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Kadant Inc | Thomas Andrew Blanchard | Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2026 | 768 | 768 | - | - | Restricted Stock Unit | |
| Kadant Inc | Thomas Andrew Blanchard | Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2026 | 411 | 1,671 (0%) | 0% | - | Common Stock | |
| Kadant Inc | Thomas Andrew Blanchard | Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2026 | 411 | 0 | - | - | Restricted Stock Unit | |
| Kadant Inc | Thomas Andrew Blanchard | Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2026 | 303 | 1,862 (0%) | 0% | - | Common Stock | |
| Kadant Inc | Thomas Andrew Blanchard | Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2026 | 303 | 303 | - | - | Restricted Stock Unit | |
| Kadant Inc | Thomas Andrew Blanchard | Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2026 | 219 | 2,008 (0%) | 0% | - | Common Stock | |
| Kadant Inc | Thomas Andrew Blanchard | Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2026 | 219 | 438 | - | - | Restricted Stock Unit | |
| Kadant Inc | Thomas Andrew Blanchard | Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2026 | 192 | 192 | - | - | Restricted Stock Unit | |
| Kadant Inc | Thomas Andrew Blanchard | Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 334.17 per share. | 10 Mar 2026 | 159 | 1,512 (0%) | 0% | 334.2 | 53,133 | Common Stock |
| Kadant Inc | Thomas Andrew Blanchard | Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 334.17 per share. | 10 Mar 2026 | 117 | 1,745 (0%) | 0% | 334.2 | 39,098 | Common Stock |
| Kadant Inc | Thomas Andrew Blanchard | Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 334.16 per share. | 10 Mar 2026 | 85 | 1,923 (0%) | 0% | 334.2 | 28,404 | Common Stock |
| Kadant Inc | Thomas Andrew Blanchard | Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2026 | 78 | 1,590 (0%) | 0% | - | Common Stock | |
| Kadant Inc | Thomas Andrew Blanchard | Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2026 | 78 | 0 | - | - | Restricted Stock Unit | |
| Kadant Inc | Thomas Andrew Blanchard | Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2026 | 72 | 1,817 (0%) | 0% | - | Common Stock | |
| Kadant Inc | Thomas Andrew Blanchard | Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2026 | 72 | 72 | - | - | Restricted Stock Unit | |
| Kadant Inc | Thomas Andrew Blanchard | Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2026 | 57 | 1,980 (0%) | 0% | - | Common Stock | |
| Kadant Inc | Thomas Andrew Blanchard | Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2026 | 57 | 114 | - | - | Restricted Stock Unit | |
| Kadant Inc | Thomas Andrew Blanchard | Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 334.16 per share. | 10 Mar 2026 | 31 | 1,559 (0%) | 0% | 334.2 | 10,359 | Common Stock |
| Kadant Inc | Thomas Andrew Blanchard | Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 334.18 per share. | 10 Mar 2026 | 28 | 1,789 (0%) | 0% | 334.2 | 9,357 | Common Stock |
| Kadant Inc | Thomas Andrew Blanchard | Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 334.17 per share. | 10 Mar 2026 | 23 | 1,957 (0%) | 0% | 334.2 | 7,686 | Common Stock |
| Kforce Inc | Andrew G. Thomas | Chief Experience Officer | Other type of transaction at price $ 0.00 per share. | 06 Mar 2026 | 617 | 117,848 (0%) | 0% | 0 | Common Stock | |
| Kforce Inc | Andrew G. Thomas | Chief Experience Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2025 | 22,413 | 117,231 (0%) | 0% | 0 | Common Stock | |
| Kforce Inc | Andrew G. Thomas | Chief Experience Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 31.41 per share. | 27 Dec 2025 | 2,541 | 94,818 (0%) | 0% | 31.4 | 79,813 | Common Stock |
| Kforce Inc | Andrew G. Thomas | Chief Experience Officer | Other type of transaction at price $ 0.00 per share. | 05 Dec 2025 | 390 | 97,359 (0%) | 0% | 0 | Common Stock | |
| Kforce Inc | Andrew G. Thomas | Chief Experience Officer | Other type of transaction at price $ 0.00 per share. | 12 Sep 2025 | 376 | 96,969 (0%) | 0% | 0 | Common Stock | |
| Kadant Inc | Thomas Andrew Blanchard | Vice President | Sale of securities on an exchange or to another person at price $ 343.00 per share. | 18 Aug 2025 | 714 | 1,188 (0%) | 0% | 343 | 244,902 | Common Stock |
| Medifast Inc | Andrea B. Thomas | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jun 2025 | 11,168 | 24,017 (0%) | 0% | 0 | Common Stock | |
| Kforce Inc | Andrew G. Thomas | Chief Experience Officer | Other type of transaction at price $ 0.00 per share. | 13 Jun 2025 | 289 | 96,593 (0%) | 0% | 0 | Common Stock | |
| Kadant Inc | Thomas Andrew Blanchard | Vice President | Sale of securities on an exchange or to another person at price $ 341.59 per share. | 19 Mar 2025 | 325 | 1,902 (0%) | 0% | 341.6 | 111,018 | Common Stock |
| Kadant Inc | Thomas Andrew Blanchard | Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2025 | 411 | 411 | - | - | Restricted Stock Unit | |
| Kadant Inc | Thomas Andrew Blanchard | Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2025 | 411 | 2,039 (0%) | 0% | - | Common Stock | |
| Kadant Inc | Thomas Andrew Blanchard | Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2025 | 303 | 606 | - | - | Restricted Stock Unit | |
| Kadant Inc | Thomas Andrew Blanchard | Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2025 | 303 | 2,270 (0%) | 0% | - | Common Stock | |
| Kadant Inc | Thomas Andrew Blanchard | Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2025 | 260 | 1,669 (0%) | 0% | - | Common Stock | |
| Kadant Inc | Thomas Andrew Blanchard | Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2025 | 260 | 0 | - | - | Restricted Stock Unit | |
| Kadant Inc | Thomas Andrew Blanchard | Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 376.16 per share. | 10 Mar 2025 | 126 | 1,913 (0%) | 0% | 376.2 | 47,396 | Common Stock |
| Kadant Inc | Thomas Andrew Blanchard | Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 376.16 per share. | 10 Mar 2025 | 93 | 2,177 (0%) | 0% | 376.2 | 34,983 | Common Stock |
| Kadant Inc | Thomas Andrew Blanchard | Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 376.16 per share. | 10 Mar 2025 | 80 | 1,589 (0%) | 0% | 376.2 | 30,093 | Common Stock |
| Kadant Inc | Thomas Andrew Blanchard | Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2025 | 79 | 78 | - | - | Restricted Stock Unit | |
| Kadant Inc | Thomas Andrew Blanchard | Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2025 | 79 | 1,992 (0%) | 0% | - | Common Stock | |
| Kadant Inc | Thomas Andrew Blanchard | Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2025 | 73 | 144 | - | - | Restricted Stock Unit | |
| Kadant Inc | Thomas Andrew Blanchard | Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2025 | 73 | 2,250 (0%) | 0% | - | Common Stock | |
| Kadant Inc | Thomas Andrew Blanchard | Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2025 | 57 | 0 | - | - | Restricted Stock Unit | |
| Kadant Inc | Thomas Andrew Blanchard | Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2025 | 57 | 1,646 (0%) | 0% | - | Common Stock | |
| Kadant Inc | Thomas Andrew Blanchard | Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 376.16 per share. | 10 Mar 2025 | 25 | 1,967 (0%) | 0% | 376.2 | 9,404 | Common Stock |
| Kadant Inc | Thomas Andrew Blanchard | Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 376.17 per share. | 10 Mar 2025 | 23 | 2,227 (0%) | 0% | 376.2 | 8,652 | Common Stock |
| Kadant Inc | Thomas Andrew Blanchard | Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 376.17 per share. | 10 Mar 2025 | 18 | 1,628 (0%) | 0% | 376.2 | 6,771 | Common Stock |
| Kforce Inc | Andrew G. Thomas | Chief Experience Officer | Other type of transaction at price $ 0.00 per share. | 07 Mar 2025 | 220 | 96,304 (0%) | 0% | 0 | Common Stock | |
| Kadant Inc | Thomas Andrew Blanchard | Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 684 | 684 | - | - | Restricted Stock Unit | |
| Kadant Inc | Thomas Andrew Blanchard | Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 171 | 171 | - | - | Restricted Stock Unit | |
| Kforce Inc | Andrew G. Thomas | Chief Experience Officer | Sale of securities on an exchange or to another person at price $ 51.79 per share. | 10 Feb 2025 | 7,100 | 96,084 (0%) | 0% | 51.8 | 367,709 | Common Stock |
| Kforce Inc | Andrew G. Thomas | Chief Experience Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2024 | 11,287 | 103,184 (0%) | 0% | 0 | Common Stock | |
| Kforce Inc | Andrew G. Thomas | Chief Experience Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 56.71 per share. | 27 Dec 2024 | 2,730 | 91,897 (0%) | 0% | 56.7 | 154,818 | Common Stock |
| Kforce Inc | Andrew G. Thomas | Chief Experience Officer | Other type of transaction at price $ 0.00 per share. | 06 Dec 2024 | 183 | 94,627 (0%) | 0% | 0 | Common Stock | |
| Kforce Inc | Andrew G. Thomas | Chief Experience Officer | Other type of transaction at price $ 0.00 per share. | 13 Sep 2024 | 173 | 94,444 (0%) | 0% | 0 | Common Stock | |
| Medifast Inc | Andrea B. Thomas | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 6,596 | 12,849 (0%) | 0% | 0 | Common Stock | |
| Kforce Inc | Andrew G. Thomas | Chief Experience Officer | Other type of transaction at price $ 0.00 per share. | 14 Jun 2024 | 176 | 94,271 (0%) | 0% | 0 | Common Stock | |
| Kforce Inc | Andrew G. Thomas | Chief Experience Officer | Sale of securities on an exchange or to another person at price $ 61.43 per share. | 04 Jun 2024 | 4,801 | 94,095 (0%) | 0% | 61.4 | 294,925 | Common Stock |
| Kforce Inc | Andrew G. Thomas | Chief Experience Officer | Other type of transaction at price $ 0.00 per share. | 15 Mar 2024 | 157 | 98,896 (0%) | 0% | 0 | Common Stock | |
| Kadant Inc | Thomas Andrew Blanchard | Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2024 | 411 | 822 | - | - | Restricted Stock Unit | |
| Kadant Inc | Thomas Andrew Blanchard | Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2024 | 411 | 1,392 (0%) | 0% | - | Common Stock | |
| Kadant Inc | Thomas Andrew Blanchard | Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2024 | 261 | 260 | - | - | Restricted Stock Unit | |
| Kadant Inc | Thomas Andrew Blanchard | Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2024 | 261 | 1,021 (0%) | 0% | - | Common Stock | |
| Kadant Inc | Thomas Andrew Blanchard | Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2024 | 128 | 800 (0%) | 0% | - | Common Stock | |
| Kadant Inc | Thomas Andrew Blanchard | Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2024 | 128 | 0 | - | - | Restricted Stock Unit | |
| Kadant Inc | Thomas Andrew Blanchard | Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 327.00 per share. | 10 Mar 2024 | 126 | 1,266 (0%) | 0% | 327 | 41,202 | Common Stock |
| Kadant Inc | Thomas Andrew Blanchard | Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 327.00 per share. | 10 Mar 2024 | 80 | 941 (0%) | 0% | 327 | 26,160 | Common Stock |
| Kadant Inc | Thomas Andrew Blanchard | Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2024 | 79 | 157 | - | - | Restricted Stock Unit | |
| Kadant Inc | Thomas Andrew Blanchard | Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2024 | 79 | 1,345 (0%) | 0% | - | Common Stock | |
| Kadant Inc | Thomas Andrew Blanchard | Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2024 | 58 | 57 | - | - | Restricted Stock Unit | |
| Kadant Inc | Thomas Andrew Blanchard | Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2024 | 58 | 999 (0%) | 0% | - | Common Stock | |
| Kadant Inc | Thomas Andrew Blanchard | Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 327.00 per share. | 10 Mar 2024 | 40 | 760 (0%) | 0% | 327 | 13,080 | Common Stock |
| Kadant Inc | Thomas Andrew Blanchard | Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 327.00 per share. | 10 Mar 2024 | 25 | 1,320 (0%) | 0% | 327 | 8,175 | Common Stock |
| Kadant Inc | Thomas Andrew Blanchard | Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 327.00 per share. | 10 Mar 2024 | 18 | 981 (0%) | 0% | 327 | 5,886 | Common Stock |
| Kadant Inc | Thomas Andrew Blanchard | Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2024 | 867 | 867 | - | - | Restricted Stock Unit | |
| Kadant Inc | Thomas Andrew Blanchard | Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2024 | 217 | 217 | - | - | Restricted Stock Unit | |
| KalVista Pharma Inc | Crockett Thomas Andrew | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Feb 2024 | 54,415 | 236,091 (1%) | 0% | - | Common Stock | |
| KalVista Pharma Inc | Crockett Andrew Thomas | Director, CEO | Sale of securities on an exchange or to another person at price $ 14.11 per share. | 17 Feb 2024 | 24,888 | 211,203 (1%) | 0% | 14.1 | 351,289 | Common Stock |
| KalVista Pharma Inc | Andrew Crockett Thomas | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Feb 2024 | 20,833 | 20,834 | - | - | Performance Stock Units | |
| KalVista Pharma Inc | Crockett Thomas Andrew | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Feb 2024 | 20,833 | 62,500 | - | - | Performance Stock Units | |
| KalVista Pharma Inc | Andrew Thomas Crockett | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Feb 2024 | 6,944 | 48,612 | - | - | Restricted Stock Unit | |
| KalVista Pharma Inc | Crockett Andrew Thomas | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Feb 2024 | 5,805 | 52,245 | - | - | Restricted Stock Unit | |
| KalVista Pharma Inc | Crockett Thomas Andrew | Director, CEO | Sale of securities on an exchange or to another person at price $ 15.01 per share. | 14 Feb 2024 | 58,356 | 181,676 (1%) | 0% | 15.0 | 875,883 | Common Stock |
| KalVista Pharma Inc | Thomas Andrew Crockett | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2024 | 122,500 | 240,032 (1%) | 0% | - | Common Stock | |
| KalVista Pharma Inc | Crockett Andrew Thomas | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2024 | 83,333 | 83,333 | - | - | Performance Stock Units | |
| KalVista Pharma Inc | Andrew Thomas Crockett | Director, CEO | Sale of securities on an exchange or to another person at price $ 16.18 per share. | 01 Feb 2024 | 9,300 | 118,232 (0%) | 0% | 16.2 | 150,428 | Common Stock |
| KalVista Pharma Inc | Andrew Crockett Thomas | Director, CEO | Sale of securities on an exchange or to another person at price $ 16.81 per share. | 01 Feb 2024 | 700 | 117,532 (0%) | 0% | 16.8 | 11,770 | Common Stock |
| Biomea Fusion Inc | Andrew Thomas Butler | Director, Chief Executive Officer, Ten Percent Owner | 17 Jan 2024 | 407,502 | 407,502 | - | - | Stock Option (Right to Buy) | ||
| Kforce Inc | Andrew G. Thomas | Chief Experience Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2023 | 7,697 | 98,739 (0%) | 0% | 0 | Common Stock | |
| Kforce Inc | Andrew G. Thomas | Chief Experience Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2023 | 2,131 | 91,042 (0%) | 0% | 0 | Common Stock | |
| KalVista Pharma Inc | Crockett Andrew Thomas | Director, CEO | Sale of securities on an exchange or to another person at price $ 12.02 per share. | 27 Dec 2023 | 30,000 | 127,532 (0%) | 0% | 12.0 | 360,453 | Common Stock |
| Kforce Inc | Thomas G. Andrew | Chief Experience Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 67.84 per share. | 27 Dec 2023 | 3,105 | 88,911 (0%) | 0% | 67.8 | 210,643 | Common Stock |
| Kforce Inc | G. Andrew Thomas | Chief Experience Officer | Other type of transaction at price $ 0.00 per share. | 15 Dec 2023 | 164 | 92,016 (0%) | 0% | 0 | Common Stock | |
| Medifast Inc | Andrea B. Thomas | Director | Purchase of securities on an exchange or from another person at price $ 69.42 per share. | 07 Nov 2023 | 50 | 6,253 (0%) | 0% | 69.4 | 3,471 | Common Stock |
| Kadant Inc | Thomas Andrew Blanchard | Vice President | Sale of securities on an exchange or to another person at price $ 219.06 per share. | 25 Sep 2023 | 454 | 672 (0%) | 0% | 219.1 | 99,453 | Common Stock |
| Kadant Inc | Thomas Andrew Blanchard | Vice President | Sale of securities on an exchange or to another person at price $ 220.50 per share. | 19 Sep 2023 | 175 | 1,126 (0%) | 0% | 220.5 | 38,587 | Common Stock |
| KalVista Pharma Inc | Thomas Andrew Crockett | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Aug 2023 | 33,582 | 161,632 (0%) | 0% | - | Common Stock | |
| KalVista Pharma Inc | Thomas Andrew Crockett | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Aug 2023 | 20,833 | 0 | - | - | Performance Stock Unit | |
| KalVista Pharma Inc | Thomas Andrew Crockett | Director, CEO | Sale of securities on an exchange or to another person at price $ 10.73 per share. | 17 Aug 2023 | 14,876 | 146,756 (0%) | 0% | 10.7 | 159,602 | Common Stock |
| KalVista Pharma Inc | Thomas Andrew Crockett | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Aug 2023 | 6,944 | 62,501 | - | - | Restricted Stock Unit | |
| KalVista Pharma Inc | Thomas Andrew Crockett | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Aug 2023 | 5,805 | 63,855 | - | - | Restricted Stock Unit |